Lymphangitic carcinomatosis as the initial manifestation of primary signet-ring cell adenocarcinoma of the lung: A case report.

Signet-ring cell lung adenocarcinoma lung cancer lymphangitic carcinomatosis

Journal

Rare tumors
ISSN: 2036-3605
Titre abrégé: Rare Tumors
Pays: England
ID NLM: 101526926

Informations de publication

Date de publication:
2023
Historique:
received: 03 08 2022
accepted: 28 02 2023
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 21 3 2023
Statut: epublish

Résumé

Signet-ring cell carcinomas are an aggressive, poorly differentiated, and highly invasive adenocarcinoma carrying a poor prognosis. Most of these tumors originate in gastrointestinal organs; however, primary lung signet-ring cell adenocarcinomas can rarely occur. Tumoral lymphatic infiltration is a complication of these tumors and can cause phenomena such as lymphangitic carcinomatosis, characterized by a nodular thickening of the pleura, pleural effusions, and mediastinal lymphadenopathies. We report a case of a 63-year-old ex-smoker with a 2-week clinical course of dyspnea and pleuritic chest pain in which a nodular thickening of the pleura and pleural effusion were documented and led to the diagnosis of a primary signet-ring cell adenocarcinoma of the lung with lymphangitic carcinomatosis. This complication has never been described in the context of a primary lung tumor of this subtype. Both entities carry a high mortality and have no therapeutical options. This report adds to the information available about them.

Identifiants

pubmed: 36937819
doi: 10.1177/20363613231164017
pii: 10.1177_20363613231164017
pmc: PMC10014970
doi:

Types de publication

Case Reports

Langues

eng

Pagination

20363613231164017

Informations de copyright

© The Author(s) 2023.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Transl Cancer Res. 2020 Feb;9(2):620-628
pubmed: 35117407
Am J Case Rep. 2019 Dec 17;20:1888-1891
pubmed: 31844036
BMJ Case Rep. 2013 Sep 20;2013:
pubmed: 24057330
Postgrad Med. 2019 Jun;131(5):309-318
pubmed: 30900501
Ann Surg. 2009 Dec;250(6):878-87
pubmed: 19855261
BMC Res Notes. 2012 Nov 16;5:638
pubmed: 23158653
Bosn J Basic Med Sci. 2021 Dec 01;21(6):752-759
pubmed: 33596400
Oncology. 2007;72(1-2):64-8
pubmed: 18004078
J R Coll Surg Edinb. 1996 Feb;41(1):7-13
pubmed: 8930034
Hum Pathol. 1989 Nov;20(11):1097-102
pubmed: 2478443
Expert Rev Gastroenterol Hepatol. 2018 Feb;12(2):209-214
pubmed: 29227748
J Am Osteopath Assoc. 2015 May;115(5):332-7
pubmed: 25938528
Br Med J. 1952 Sep 20;2(4785):639-41
pubmed: 14954193
J Thorac Oncol. 2010 Apr;5(4):420-7
pubmed: 20130484
Cancer Manag Res. 2018 Sep 24;10:3825-3831
pubmed: 30288113
Thorax. 1964 May;19:251-60
pubmed: 14143504
South Med J. 1986 Sep;79(9):1173-6
pubmed: 3018944
CMAJ. 2008 Aug 12;179(4):338-40
pubmed: 18695182
Hum Pathol. 1999 Apr;30(4):378-83
pubmed: 10208457
Transl Lung Cancer Res. 2021 Sep;10(9):3840-3849
pubmed: 34733632
J Clin Oncol. 2012 Oct 1;30(28):3493-8
pubmed: 22927530

Auteurs

David Corredor-Orlandelli (D)

School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.

Lina Vargas (L)

Internal Medicine Department, Fundación Cardioinfantil - LaCardio, Bogotá, Colombia.

Classifications MeSH